Titan Pharmaceuticals Inc (TTNP)

[Serenity3]

difficult to say as we do not have the actual study design but going off INVVY press release...it looks as though each patient in the active group got 2 shots/month w/first 2 months = higher bup (maybe equivalent to ~ 20mg/day) & tapering off to lower dosage the last 4 months... if that was the case, the fact that the control placebo group got only 1 sham shot a month (as opposed to the active group getting 2 shots/month) would compromise the double blind integrity of the trial itself, I would think? we'll see... the point here is that competitors are vying for market share whether it's INVVY or CAMX or ALKS or someone else & TTNP board is either going to light a fire under their management to get some revenue or their whole company is going to go up in smoke